July 24, 2019
ArunA Bio Raises $13 Million in Common Stock Financing
— Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities — — ArunA Bio…
Pharmaceuticals, Biotechnology and Life Sciences
— Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities — — ArunA Bio…
ATHENS, Ga–(BUSINESS WIRE)–ArunA Bio, a leader in the development of exosomes and exosome therapeutics for the treatment of neurodegenerative disorders,…